Zhiwen He

729 total citations
21 papers, 544 citations indexed

About

Zhiwen He is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Zhiwen He has authored 21 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Zhiwen He's work include Ubiquitin and proteasome pathways (3 papers), Berberine and alkaloids research (2 papers) and Advanced Breast Cancer Therapies (2 papers). Zhiwen He is often cited by papers focused on Ubiquitin and proteasome pathways (3 papers), Berberine and alkaloids research (2 papers) and Advanced Breast Cancer Therapies (2 papers). Zhiwen He collaborates with scholars based in China, United States and Israel. Zhiwen He's co-authors include Rongzhen Xu, Xiao-Fang Yu, Gongying Chen, Wenyan Zhang, Tao Wang, Yongwen Luo, Bo Wang, Gang Wang, Yanxue Wang and Shuiqing Chi and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of Molecular Biology.

In The Last Decade

Zhiwen He

19 papers receiving 539 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhiwen He China 11 241 185 143 134 91 21 544
Rachel A. Cleary United States 10 203 0.8× 217 1.2× 117 0.8× 139 1.0× 50 0.5× 13 571
Songcheng Ying China 14 218 0.9× 102 0.6× 53 0.4× 179 1.3× 74 0.8× 28 485
Octavio A. Quiñones United States 13 216 0.9× 92 0.5× 68 0.5× 110 0.8× 76 0.8× 17 498
Weiyi Gao China 10 367 1.5× 34 0.2× 39 0.3× 51 0.4× 45 0.5× 16 589
Besma Bel Hadj Jrad Tunisia 13 203 0.8× 17 0.1× 70 0.5× 133 1.0× 82 0.9× 36 488
Zhu Ming China 9 220 0.9× 116 0.6× 54 0.4× 68 0.5× 33 0.4× 15 377
Shen Dai United States 12 322 1.3× 90 0.5× 34 0.2× 173 1.3× 69 0.8× 18 640
Abhishek Tripathi United States 11 291 1.2× 72 0.4× 45 0.3× 115 0.9× 148 1.6× 17 446
Catherine R. Cochrane Australia 9 229 1.0× 97 0.5× 43 0.3× 34 0.3× 133 1.5× 11 396
Sharon Tamir United States 11 303 1.3× 23 0.1× 112 0.8× 79 0.6× 57 0.6× 25 524

Countries citing papers authored by Zhiwen He

Since Specialization
Citations

This map shows the geographic impact of Zhiwen He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhiwen He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhiwen He more than expected).

Fields of papers citing papers by Zhiwen He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhiwen He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhiwen He. The network helps show where Zhiwen He may publish in the future.

Co-authorship network of co-authors of Zhiwen He

This figure shows the co-authorship network connecting the top 25 collaborators of Zhiwen He. A scholar is included among the top collaborators of Zhiwen He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhiwen He. Zhiwen He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Guang, Zhiwen He, Yanbiao Wang, et al.. (2024). Tunable Electronic and Magnetic Properties of 3d Transition Metal Atom-Intercalated Transition Metal Dichalcogenides: A Density Functional Theory Study. Inorganics. 12(9). 237–237. 2 indexed citations
2.
Li, Jian, Lin Shen, Yanhong Gu, et al.. (2024). Preliminary activity and safety results of KRAS G12C inhibitor glecirasib (JAB-21822) in patients with pancreatic cancer and other solid tumors.. Journal of Clinical Oncology. 42(3_suppl). 604–604. 22 indexed citations
3.
Zhang, Peng, Liang Chen, Fenfang Zhou, et al.. (2023). NRP1 promotes prostate cancer progression via modulating EGFR-dependent AKT pathway activation. Cell Death and Disease. 14(2). 159–159. 29 indexed citations
4.
Luo, Yongwen, Zhiwen He, Wei Liu, et al.. (2022). DTL Is a Prognostic Biomarker and Promotes Bladder Cancer Progression through Regulating the AKT/mTOR axis. Oxidative Medicine and Cellular Longevity. 2022(1). 23 indexed citations
5.
Chen, Siming, Zhiwen He, Shijie Yao, et al.. (2022). Enhanced Recovery After Surgery Protocol Optimizes Results and Cost of Laparoscopic Radical Nephrectomy. Frontiers in Oncology. 12. 840363–840363. 8 indexed citations
6.
Feng, Tao, et al.. (2022). On the irreducible characters of Suzuki p-groups. Journal of Algebra and Its Applications. 23(1).
7.
Chen, Siming, Zhiwen He, Fenfang Zhou, et al.. (2021). PRR11 promotes ccRCC tumorigenesis by regulating E2F1 stability. JCI Insight. 6(19). 9 indexed citations
8.
He, Zhiwen, Siming Chen, Mengxin Lü, et al.. (2021). A combination of laparoscopic approach and ERAS pathway optimizes outcomes and cost for adrenalectomy. Updates in Surgery. 74(2). 519–525. 5 indexed citations
9.
He, Zhiwen, et al.. (2021). Linear codes of 2-designs as subcodes of the generalized Reed-Muller codes. Cryptography and Communications. 13(3). 407–423.
10.
Tao, Huangheng, Zhiwen He, Xinghuan Wang, et al.. (2021). BRCC3 Promotes Tumorigenesis of Bladder Cancer by Activating the NF-κB Signaling Pathway Through Targeting TRAF2. Frontiers in Cell and Developmental Biology. 9. 720349–720349. 18 indexed citations
11.
Luo, Yongwen, Jun Zhou, Jianing Tang, et al.. (2021). MINDY1 promotes bladder cancer progression by stabilizing YAP. Cancer Cell International. 21(1). 395–395. 22 indexed citations
12.
Wang, Bo, Zijian Wang, Lizhi Han, et al.. (2019). Prognostic significance of cyclin D3 expression in malignancy patients: a meta-analysis. Cancer Cell International. 19(1). 158–158. 12 indexed citations
13.
Wang, Bo, et al.. (2019). Effect of virtual reality on balance and gait ability in patients with Parkinson’s disease: a systematic review and meta-analysis. Clinical Rehabilitation. 33(7). 1130–1138. 57 indexed citations
14.
He, Zhiwen, Julie O’Neal, William C. Wilson, et al.. (2015). Deletion of Rb1 induces both hyperproliferation and cell death in murine germinal center B cells. Experimental Hematology. 44(3). 161–165.e4. 8 indexed citations
15.
He, Zhiwen, Wenyan Zhang, Gongying Chen, Rongzhen Xu, & Xiao-Fang Yu. (2008). Characterization of Conserved Motifs in HIV-1 Vif Required for APOBEC3G and APOBEC3F Interaction. Journal of Molecular Biology. 381(4). 1000–1011. 115 indexed citations
16.
He, Zhiwen, et al.. (2007). Berbamine selectively induces apoptosis of human acute promyelocytic leukemia cells via survivin-mediated pathway. Chinese Medical Journal. 120(9). 802–806. 21 indexed citations
17.
He, Zhiwen, et al.. (2006). [Effects of berbamine on growth of leukemia cell line NB4 and its mechanism].. PubMed. 35(2). 209–14. 8 indexed citations
18.
Zhang, Xiao­hong, et al.. (2006). Roles of Phosphorylated p210bcr/abl and Hsp90 Protein in Apoptosis Induced by Berbamine in K562 Cells.. Blood. 108(11). 4418–4418. 1 indexed citations
19.
Xu, Rongzhen, Shu Zheng, Qinghua Dong, et al.. (2005). Overexpression of Shp2 tyrosine phosphatase is implicated in leukemogenesis in adult human leukemia. Blood. 106(9). 3142–3149. 100 indexed citations
20.
Zhao, Xiaoying, Zhiwen He, Dong Wu, & Rongzhen Xu. (2005). Studies on the Effects of Berbamine on the Human Leukemia Cell Line NB4.. Blood. 106(11). 4422–4422. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rachel A. Cleary Breakdown of academic impact, for papers by Songcheng Ying Breakdown of academic impact, for papers by Octavio A. Quiñones Breakdown of academic impact, for papers by Weiyi Gao Breakdown of academic impact, for papers by Besma Bel Hadj Jrad Breakdown of academic impact, for papers by Zhu Ming Breakdown of academic impact, for papers by Shen Dai Breakdown of academic impact, for papers by Abhishek Tripathi Breakdown of academic impact, for papers by Catherine R. Cochrane Breakdown of academic impact, for papers by Sharon Tamir
Rankless by CCL
2026